Subscribe to RSS - ResMed

ResMed

ResMed promotes Michael Farrell to CEO

 - 
02/21/2013

POWAY, Calif. – Michael “Mick” Farrell, president of ResMed’s Americas division since 2011, will replace his father, Peter Farrell, as CEO and be appointed to the company’s board effective March 1, according to a press release.

ResMed sets ex-dividend trading date

 - 
02/12/2013

SAN DIEGO – ResMed will begin trading ex-dividends this Thursday on Feb. 14, according to an article from Nasdaq.

ResMed CEO sells 400,000 shares

 - 
02/06/2013

SAN DIEGO – ResMed CEO and Executive Chairman Peter Farrell sold 400,000 shares at an average price of $46.98 on Jan. 30, according to an article from Nasdaq.com.

ResMed reports double-digit increases

'We’ve been pioneering a market dynamic that is finally getting traction'
 - 
01/25/2013

SAN DIEGO – With home sleep testing (HST) gaining ground and new products in the works, 2013 should be a good year for ResMed, officials reported last week.

In brief: Industry keeps up pressure, ResMed nears CEO decision

 - 
12/28/2012

WASHINGTON – It's impossible to predict whether lawmakers will reach a deal on the so-called fiscal cliff by the new year, but HME industry stakeholders say don’t get distracted by the bigger picture.

ResMed to select new CEO in early 2013

 - 
12/26/2012

SAN DIEGO – ResMed is on track to choose an internal candidate as its next CEO in early 2013, The Australian has reported. The two candidates vying for the position: Michael Farrell, president of Americas; and Robert Douglas, COO.

In brief: OIG rehashes HME recommendations, ResMed mulls move

 - 
12/07/2012

In brief: OIG rehashes HME recommendations, ResMed mulls move

ResMed mulls move

 - 
12/06/2012

SAN DIEGO – ResMed is evaluating whether it should move its headquarters out of California, according to news reports.

Supplies market: 'It's an attractive space'

 - 
10/26/2012

SAN DIEGO – ResMed officials remain confident in the growth of the supplies market for CPAP devices, they said during an earnings call Oct. 25.

ResMed announces record quarter

 - 
10/26/2012

SAN DIEGO – ResMed this week reported revenue of $339.7 million for the quarter ended Sept. 30, 2012, an 8% increase over the same quarter last year. Net income was $71.3 million, a 41% increase; and earnings per share were $0.49, a 48% increase.

Pages